Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway

Fig. 1

FLVCR1-AS1 expression is suppressed in PC tissues and cell lines and is correlated with later pathological stage and grave prognosis. A FLVCR1-AS1 expression in 77 pairs of PC tumor tissues and adjacent normal tissues. B The expression of FLVCR1-AS1 in PC patients with lymph node metastasis. C FLVCR1-AS1 expression in the included PC patients was divided according to cancer stage (n = 77). D By drawing the ROC curve, the demarcation points of low and high FLVCR1-AS1 expression were distinguished. E Overall survival (OS) and disease-free survival (DFS) based on FLVCR1-AS1 expression levels were determined using the Kaplan-Meier plotter databases. F Prognostic analysis of FLVCR1-AS1 using clinical prognostic data of 51 patients from our center. G FLVCR1-AS1 expression in PC cell lines (Bxpc-3, CFPAC-1, MIA PaCa-2, PANC-1, and PATU-8988) compared with that of normal pancreatic ductal epithelial cell line HPNE detected by qRT-PCR. *P < 0.05; ***P < 0.001. All experiments were repeated three times

Back to article page